期刊文献+

内皮抑素联合微波消融治疗裸鼠肾癌移植瘤研究 被引量:2

Microwave ablation combined with endostatin in treatment of human kidney carcinoma transplanted in nude mice
下载PDF
导出
摘要 目的研究内皮抑素联合微波消融对裸鼠肾癌移植瘤的抑制作用。方法将人源性肾癌细胞接种到48只小鼠的背部皮下,肿瘤直径约1.5 cm时随机分成4组,对照组:隔日尾静脉生理盐水;联合治疗组:隔日尾静脉推注内皮抑素+皮下肿瘤微波消融;微波消融组:皮下肿瘤微波消融;内皮抑素组:隔日尾静脉推注内皮抑素。首先对联合治疗组及微波消融组局部皮下肾移植瘤进行微波消融治疗,其后经尾静脉注射药物。14天后每组处死6只小鼠,比较各组瘤重,计算抑瘤率,检测血浆VEGF浓度,剩余6只小鼠观察其存活期。结果联合治疗组小鼠肿瘤体积显著小于其他各组(P<0.0 5),其血浆VEGF水平较其他各组显著减低(P<0.0 5),存活时间较其他各组显著延长(P<0.05)。结论内皮抑素联合微波消融抗肿瘤作用优于单用内皮抑素或微波消融治疗,并使小鼠存活期延长。 Objective To investigate microwave ablation combined with endostatin in treatment of human kidney carcinoma transplanted in nude mice.Methods Human kidney Ketr-3 kidney cells were subcutaneously implanted in 48 BalB/C-nu/nu mice.When the diameter of tumor reached 1.5 cm the animals were randomly divided into 4 groups: in microwave group the mice were treated with microwave ablation;in endostatin group endostatin was injected through tail vein;in combination group the mice received endostatin injection and microwave ablation;in control group normal saline was injected.The tumor weight and the inhibition rate were calculated,and the survival time was observed.Plasma concentrations of vascular endothelial growth factor(VEGF) of tumors were measured by ELISA method.Results The tumor weight was lower in the combined treatment group than in the other groups(P0.05).Plasma VEGF in combined treatment group was significantly decreased compared with that of other groups(P0.05).Conclusion Microwave ablation combined with endostatin shows better therapeutical effects than each method used alone in treatment of transplanted human kidney carcinoma in nude mice.
机构地区 诸城市人民医院
出处 《实用肿瘤杂志》 CAS 北大核心 2010年第6期631-633,共3页 Journal of Practical Oncology
关键词 肾肿瘤/治疗 内皮抑素类/治疗应用 微波/治疗应用 导管消融术/方法 肿瘤移植 血管内皮生长因子A 疾病模型 动物 kidney neoplasms/therapy endostatins/therapeutic use microwaves/therapeutic use catheter ablation/methods neoplasm transplantation vascular endothelial growth factor A disease models animal
  • 相关文献

参考文献6

  • 1Folkman J. Antiangiogenendostatinis in cancer therapy endostatin and its mechanisms of action [ J ]. Exp Cell Rendostatin, 2006,312(5 ) :594 - 607.
  • 2Maepherson GR, Ng SS, Forbendostatin SL, et al. Antiangiogenic activity of human endostatin is HIF-1- independent in vitro and sensitive to timing of treatment in a human saphenous vein assay [ J]. Mol Cancer Ther, 2003,2 (9) : 845 - 854.
  • 3Laln JS, Leppert JT, Yu H, et al. Exprendostatinsion of the vascu larendothelial growth factor family in tumor dissemination and disease free survival in clear call renal cell carcinoma [ J ]. J Clin Oncol, 2005,23 (Suppl) : 387.
  • 4Hanai J, Gloy J, Karumanchi SA, et al. Endostatin is a potential inhibitor of Wnt signaling [ J ]. J Cell Biol, 2002,158(3) :529 - 539.
  • 5Chamberlain JS, Gibbs RA, Ranier JE, et al. Multiplex PCR for the diagnosis of Duchenne muscular dystrophy [ M]. New York: Academic Prendostatins, 1990 : 272 - 281.
  • 6Takahashi I, Emi Y, Hasuda S, et al. Clincal application of hyperther miacombined with anticancer drugs for the treatment of solid tumors [ J]. Surgery, 2002,131 ( 1 Suppl) :78 - 84.

同被引文献14

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部